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a b s t r a c t
The koala retrovirus (KoRV), which is transitioning from an exogenous to an endogenous form, has been
associated with high mortality in koalas. For other retroviruses, the envelope protein p15E has been
considered a candidate for vaccine development. We therefore examined proviral sequence variation of
KoRV p15E in a captive Queensland and three wild southern Australian koalas. We generated 163
sequences with intact open reading frames, which grouped into 39 distinct haplotypes. Sixteen distinct
haplotypes comprising 139 of the sequences (85%) coded for the same polypeptide. Among the
remaining 23 haplotypes, 22 were detected only once among the sequences, and each had 1 or 2
non-synonymous differences from the majority sequence. Several analyses suggested that p15E was
under purifying selection. Important epitopes and domains were highly conserved across the p15E
sequences and in previously reported exogenous KoRVs. Overall, these results support the potential use
of p15E for KoRV vaccine development.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Endogenous retroviruses (ERVs) originate when exogenous retro-
viruses integrate into the genomes of host germ line cells (Boeke and
Stoye, 1997; Bromham, 2002; Cofﬁn, 2004; Stoye, 2012). ERVs are
subsequently transmitted vertically in the host lineage, from parent to
offspring through Mendelian inheritance (Boeke and Stoye, 1997;
Bromham, 2002; Cofﬁn, 2004; Stoye, 2012). The koala retrovirus
(KoRV) is the only retrovirus known to be in the midst of transitioning
from exogenous to endogenous form in its host species, the koala
(Phascolarctos cinereus) (Tarlinton et al., 2006). Koala populations in
northern Australia exhibit 100% prevalence of KoRV while in southern
Australian populations many koalas are completely free of the virus.
This suggests that KoRV initially affected koalas in northern Australia
and is currently spreading to southern populations (Simmons et al.,
2012; Tarlinton et al., 2006). Simmons et al. (2012) estimated that
northern Australian koalas carry an average of 165 copies of KoRV per
cell while southern Australian koalas carry 1.29104 to 1.50 copies
per cell (although some southern Australian koalas are completely free
of KoRV). KoRV has been implicated in immunosuppression and is
thought to be associated with leukemia, lymphoid neoplasia (Tarlinton
et al., 2005), and chlamydiosis (Tarlinton et al., 2005). KoRV variants
with more limited geographic distributions, perhaps reﬂecting more
recent origins, have been reported recently (Shimode et al., 2014;
Shojima et al., 2013a, 2013b; Xu et al., 2013); some sequence variants
may be especially malignant (Shojima et al., 2013b; Xu et al., 2013).
Many koala populations appear to have low genetic diversity espe-
cially in southern Australia (Cristescu et al., 2009; Houlden et al., 1996;
Taylor et al., 1997; Tsangaras et al., 2012). Reduced genetic diversity
can lower the ability of a population to resist pathogens (Spielman
et al., 2004). The development of vaccines against KoRV may be an
option for maintaining KoRV-free koala populations and to protect
koalas in zoos.
KoRV is a gammaretrovirus related to the gibbon ape leukemia
virus (GALV) (Hanger et al., 2000). Immunization and vaccine
experiments have been conducted on various gammaretroviruses.
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For porcine endogenous retrovirus (PERV) and feline leukemia virus
(FeLV), the transmembrane (TM) protein p15E and the surface (SU)
protein gp70, which are parts of the viral envelope, have been tested
for their potential for immunizing the host species (Denner et al.,
2012; Kaulitz et al., 2011; Langhammer et al., 2011; Waechter et al.,
2013). Gammaretrovirus envelope proteins are less variable than
those of HIV-1 (Denner, 2013; Mansky and Temin, 1995). Immuniza-
tion studies with the envelope proteins of gammaretroviruses PERV,
FELV and KoRV across mammalian species have consistently obtained
neutralizing antibodies. When both p15E and gp70 envelope proteins
have been used for immunization against PERV in various animal
species such as goats and rats, the resulting immune response and
protection proved more efﬁcient than immunizing with a single
protein (Denner et al., 2012; Kaulitz et al., 2011). Epitope mapping of
the p15E envelope protein of PERV and FeLV has identiﬁed two
epitopes that are highly conserved among gammaretroviruses and
are targets for host antibodies (Fiebig et al., 2003; Langhammer et al.,
2006). Epitope E1 is in the fusion peptide-proximal region (FPPR),
while epitope E2 is in the membrane-proximal external region
(MPER). The epitopes in p15E of PERV and epitopes in gp41 (which
corresponds to p15E) of HIV-1 are structurally and functionally
similar (Fiebig et al., 2003). It has been experimentally shown that
the MPER of HIV-1 contains at least 3 epitopes recognized by
antibodies 2F5, 4E10, and 10E8 (Huang et al., 2012; Stiegler et al.,
2001; Zwick et al., 2001, 2005). Similarly, in a recent study of PERV in
which afﬁnities of antibodies were tested for both MPER and FPPR,
antibodies directed against MPER (E2) were found to be involved in
neutralization (Waechter and Denner, 2014).
In addition to E1 and E2, p15E contains an immunosuppressive
domain that is highly conserved among different retroviruses includ-
ing the human immunodeﬁciency virus (HIV) (Denner et al., 1994).
The protein p15E also contains the heptad repeat 1 (HR1) and heptad
repeat 2 (HR2) motifs, whichmediate viral protein-protein interactions
and are important for viral fusion (Eckert and Kim, 2001; Skehel and
Wiley, 2000). Additionally, the p15E protein contains the homotrimer
interface, a domain that mediates the formation of a trimer structure
responsible for viral fusion with the target cell and infection (Eckert
and Kim, 2001; Shu et al., 1999); a chloride ion (Cl) binding site that
stabilizes the trimeric structure (Lamb et al., 2011); and a CX(6)C motif
that forms an intra-subunit disulﬁde bond in some viruses (Kobe et al.,
1999; Wallin et al., 2004). The high degree of conservation of domains
and of epitopes make the p15E polypeptide a good candidate to
consider for targeting by neutralizing antibodies (Denner and Young,
2013).
In the case of KoRV, p15E-speciﬁc neutralizing antibodies have
been shown to efﬁciently lower provirus integration (Fiebig et al.,
2006). Thus the KoRV p15E polypeptide may be a potential target
for vaccine development. Despite the important functional
domains and motifs of the KoRV p15E region, its sequence
variation or conservation have not been well characterized to
date, especially for KoRV in southern Australian koalas. In this
study, we examined the degree of sequence variation in KoRV
p15E in four koalas of different geographic origins as well as
among sequences published by previous studies (Avila-Arcos et al.,
2013; Fiebig et al., 2006; Hanger et al., 2000; Shojima et al., 2013a;
Xu et al., 2013). We also investigated the effects of this variation on
the structure and function of this biologically and clinically
important KoRV region by conducting protein structure modeling.
Results
Identiﬁcation of protein epitopes and functional residues
The position of the coding region for p15E in KoRV (GenBank:
AF151794) (Hanger et al., 2000) was determined based on homology
to gibbon ape leukemia virus (GALV; GenBank accession number
NC_001885) (Delassus et al., 1989) and feline leukemia virus (FeLV;
GenBank NC_001940) (Chen et al., 1998). KoRV p15E corresponded to
positions 7295 to 7885 (591 bp) of AF151794 (Hanger et al., 2000). The
p15E polypeptide thus consists of 197 amino acids at positions 464 to
660 of the envelope protein. Homology to these other retroviruses
allowed us to estimate that epitope 1 in KoRV would consist of amino
acids 492 to 498 of Env (29 to 35 in p15E), epitope 2 would consist of
amino acids 592 to 597 (129 to 134 in p15E), while the immunosup-
pressive domain would consist of amino acids 533 to 549 (70 to 86 in
p15E). Amino acids for both E1 and E2 were highly conserved between
the reference KoRV sequence and GALV (NC_001885) (Delassus et al.,
1989). When KoRV was aligned to PERV (AM229312) (Preuss et al.,
2006), E2 showed a higher degree of conservation than E1 among
KoRV, GALV, and PERV (Fig. 1). A high degree of conservation for the
immunosuppressive domain was also evident in an alignment across
retroviruses, as in this region there were no amino acid differences
among KoRV, GALV and PERV (Fig. 1). The Conserved Domain Database
(CDD) of NCBI was used to identify conserved regions and to infer the
functional amino acids by homology to other retroviruses. Both E2 and
the immunosuppressive domainwere veriﬁed as being conserved. The
CDD was also used to determine the position of the remaining motifs
present on the p15E region of KoRV. This analysis revealed that the
HR1 and HR2 motifs were located at positions 33–78 and 103–112,
respectively. The Cl binding site was the asparagine at position 72
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Fig. 1. Amino acid alignment of p15E in KoRV, GALV and PERV. The amino acid
residues are shown for p15E-1, which was used as the reference KoRV. Amino acid
residues in the other viruses that match the reference are indicated by dots;
residues that differ from the reference sequence are shown; dashes indicate a
shorter length for a polypeptide at the C-terminus. The immunosuppressive
domain and epitopes are indicated by boxes; the immunosuppressive domain is
fully conserved and E2 is highly conserved across the retroviruses. The two epitope
positions were estimated in KoRV and GALV by homology with the epitopes in
PERV (Fiebig et al., 2003). The position of the immunosuppressive domain was also
determined by homology to other retroviruses (Denner et al., 1994). The amino acid
sequence shown for GALV is based on translation of GenBank accession NC_001885
(Delassus et al., 1989); for PERV the translation is for PERV-C, GenBank accession
AM229312 (Preuss et al., 2006).
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(conserved among many retroviruses), the CX(6)C motif was at
position 87–94, and the homotrimer interface was composed of
several amino acids found at positions 43–112 (Fig. 2).
DNA and amino acid sequence variation of p15E
We examined the diversity of the KoRV coding region for p15E
in one northern Australian koala (Pci-SN404) kept at a North
American zoo and three southern Australian koalas (Pci-157 from
Stony Rises, Pci-128 from Brisbane Ranges, and Pci-182 from
Kangaroo Island). In total, 172 clones were sequenced across four
koalas. Nine sequences among the 172 were not in frame. One
clone in koala Pci-SN404 had a mutation that coded for a stop
codon. Two clones of Pci-128 had a deletion at nucleotide position
84 of p15E that would cause a frameshift and a premature stop
codon. Another frameshift mutation that did not cause a stop
codon was detected in six clonal sequences of Pci-157. The frame-
shift was caused by a 19 bp deletion beginning at position 553 of
Fig. 2. Amino acid variation inferred from 163 KoRV p15E DNA sequences. DNA from 4 koalas was ampliﬁed and cloned. Each clone included the complete codon sequences
of p15E. The alignment shows the inferred amino acid sequences, with the translation of the most common haplotype (p15E-1) used as a reference for the alignment.
Positions are numbered relative to the start of p15E; dots indicate matches to the reference. Among the 163 clones sequenced that had intact open reading frames, there
were 39 distinct DNA sequences, of which 16 coded for the amino acid sequence of p15E-1 (i.e., they differed only by synonymous mutations). Most of the KoRVs in Genbank
(JQ244835 to JQ244839, AF151794 and AB721500) (Avila-Arcos et al., 2013; Hanger et al., 2000; Shojima et al., 2013a) coded for the same amino acids as p15E-1. The amino
acid differences are shown for those that did not code for the same residues: KoRV-A GenBank accession DQ174772, KoRV-B NC_021704, KoRV-J OJ-4 clone 11-4 AB822553,
and KoRV-J OJ-4 11-1 (clones 11-1, 2, and 5 had identical sequences, and correspond to Genbank accessions AB823238, AB828004, and AB828005, respectively). Amino acid
residues for p15E-2 through p15E-24 represent translations of newly generated KoRV sequences that had non-synonymous mutations. The positions of epitope E1, epitope
E2, and the immunosuppressive domain were estimated based on homology to PERV-C (AM229312) (Preuss et al., 2006) and to other retroviruses (Fig. 1). The position of
each transmembrane helix was determined using HMMTOP (Tusnady and Simon, 1998, 2001). Both FPPR (E1) and MPER (E2) overlap with one of the outside tails. Non-
synonymous nucleotide mutations that were also detected in koala museum specimens (Tsangaras et al., 2014) are shown in boldface. The HR1 and HR2 motifs are shown as
underlined amino acids, the Cl binding site as an underlined and bold amino acid, the amino acids comprising the CX(6)C motif are italicized, and the amino acids of the
homotrimer interface are indicated using diamonds.
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the p15E, which would alter the 13 amino acids downstream of
the deletion and also change the stop codon at the end of p15E to
code for a residue.
The 163 clonal sequences with intact open reading frames
(ORFs) included 39 distinct haplotypes (Table 1). The most
common haplotype was present in all 4 koalas, and comprised
106 of the 163 sequences (Table S1). Of the other 38 distinctive
haplotypes, 15 had only synonymous differences when compared
to the most common haplotype. The 16 haplotypes with identical
predicted amino acid sequences represented 139 of 163 clonal
sequences with intact ORFs (Table S1), and the inferred polypep-
tide coded by these sequences was designated P15E-1. The
remaining 23 DNA sequences were distinct from each other, and
each coded for a different polypeptide with 1 or 2 residues
different from p15E-1 (Table 1, Fig. 2). Among these 23 amino
acid sequences, 5 were identiﬁed in the northern koala and 18
were detected in just one of the 3 southern koalas. One of these
polypeptides, p15E-2, appeared in two identical clonal sequences
of koala Pci-128, but was not detected in other koalas. The other
22 haplotypes were each present in only 1 clonal sequence from
just 1 koala (Table 1). We also compared the non-synonymous
nucleotide mutations present in the 22 haplotypes to p15E-1
polymorphisms identiﬁed in next generation sequencing data that
had been previously generated from 7 historical museum koalas
(Tsangaras et al., 2014). Among the non-synonymous nucleotide
substitutions present in just one of the clones generated by the
current study, 8 were also veriﬁed as a polymorphism among the
museum specimens, present at a frequency of 3% or greater within
the corresponding reads of at least one museum koala (Table 1).
Relative to the reference polypeptide p15E-1, there were two
amino acid differences predicted in polypeptides p15E-4, p15E-5,
p15E-8, and p15E-20 while 19 predicted polypeptides (including
p15E-2) differed from p15E-1 at a single amino acid (Fig. 2,
Table 1). Among 24 non-synonymous substitutions (Table S2),
only two were shared among different polypeptides: A145T (the
ﬁrst position represents the residue in p15E-1) in p15E-2, p15E-4,
and p15E-8; and V182A in p15E-4 and p15E-18. The other 22 non-
synonymous substitutions were present in only one of the haplo-
types. Of the 27 non-synonymous variants detected relative to
p15E-1, 14 had variation detected in more than one clone, or at the
same position in multiple clones (Fig. 2), or also detected in the
museum dataset. It remains possible that some of the remaining
haplotypes may represent cloning or other errors, although clon-
ing error is expected to be rare (104 to 2105) (Life Technol-
ogies Corp, personal communication).
Sequences of p15E reported by previous studies were also exam-
ined (GenBank: JQ244835 to JQ244839, AF151794, DQ174772, AB72-
1500, NC021704, AB822553, AB823238, AB828004, and AB828005)
(Avila-Arcos et al., 2013; Fiebig et al., 2006; Hanger et al., 2000;
Shojima et al., 2013a; Xu et al., 2013). For the ﬁve koala museum
Table 1
KoRV p15E non-synonymous variation across four koalas.
Polypeptide
Designation
N Non-synonymous
substitutions vs. p15E-1
Number of clones coding for the polypeptide
Northern Australia Stony Rises Brisbane Ranges Kangaroo Island
Pci-SN404 Pci-157 Pci-128 Pci-182 Total
Detected in more than one clone
KoRV-A p15E-1 16 – 37 30 32 40 139
KoRV-A p15E-2 1 1 0 0 2 0 2
Detected in only a single clone
KoRV-A p15E-3* 1 1 0 0 1 0 1
KoRV-A p15E-4 1 2 0 0 1 0 1
KoRV-A p15E-5* 1 2 0 0 1 0 1
KoRV-A p15E-6 1 1 0 0 1 0 1
KoRV-A p15E-7* 1 1 0 0 1 0 1
KoRV-A p15E-8 1 2 0 0 1 0 1
KoRV-A p15E-9* 1 1 0 0 1 0 1
KoRV-A p15E-10* 1 1 0 1 0 0 1
KoRV-A p15E-11* 1 1 0 1 0 0 1
KoRV-A p15E-12 1 1 0 1 0 0 1
KoRV-A p15E-13* 1 1 0 1 0 0 1
KoRV-A p15E-14 1 1 0 1 0 0 1
KoRV-A p15E-15 1 1 0 1 0 0 1
KoRV-A p15E-16 1 1 0 1 0 0 1
KoRV-A p15E-17 1 1 0 1 0 0 1
KoRV-A p15E-18 1 1 0 0 0 1 1
KoRV-A p15E-19 1 1 0 0 0 1 1
KoRV-A p15E-20* 1 2 1 0 0 0 1
KoRV-A p15E-21 1 1 1 0 0 0 1
KoRV-A p15E-22 1 1 1 0 0 0 1
KoRV-A p15E-23 1 1 1 0 0 0 1
KoRV-A p15E-24 1 1 1 0 0 0 1
From GenBank
KoRV-A DQ174772 1 0 0 0 0 0
KoRV-B 2 0 0 0 0 0
KoRV-J OJ-4 11-1 2 0 0 0 0 0
KoRV-J OJ-4 11-4 10 0 0 0 0 0
Total 43 42 38 41 42 163
Pci-SN404 is a zoo koala from Queensland; the other three are wild koalas from the southern Australian populations listed. N is the number of distinct haplotypes that coded
for the same polypeptide (i.e., only synonymous differences were present). The haplotypes that coded for polypeptides p15E-3 to -24 each were detected only in one clonal
sequence; some may represent cloning errors. However, for those with an asterisk (*) the same nucleotide change was detected among museum specimen KoRV
polymorphisms (Tsangaras et al. 2014), including both polymorphisms in p15E-20. Two GenBank sequences (AF151794, AB721500) code for the same polypeptide as p15E-1;
only GenBank entries that coded for different polypeptides are listed. Each listed Genbank entry coded for a distinct polypeptide: KoRV-A is GenBank number DQ174772,
KoRV-B is NC021704, KoRV-J OJ-4 11-4 is AB822553. KoRV-J OJ-4 clones 11-1, 2, and 5 (AB823238, AB828004, and AB828005, respectively) had identical sequences coding the
same polypeptide, listed here as 11-1.
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specimens collected 30 to 120 years ago, due to DNA degradation only
short sequence reads had been generated, and it was not possible to
determine the phase of SNPs that were far apart (Avila-Arcos et al.,
2013). The nucleotide sequences of AF151794 (Hanger et al., 2000) and
AB721500 (Shojima et al., 2013a) matched haplotype p15E-1H1, which
was the most common DNA sequence among our clones. Of 8 entries
in GenBank for p15E frommodern koalas, 2 coded for the same amino
acids as p15E-1. The sequence DQ174772 (Fiebig et al., 2006) coded for
one amino acid difference. Fig. 2 and Table S3 show that when
compared to p15E-1, there were 2 non-synonymous mutations in
KoRV-B (GenBank accession NC021704) (Xu et al., 2013), 2 non-
synonymous mutations in KoRV-J OJ-4 clone 11-1 (AB823238; iden-
tical in sequence to clones 11-2 and 11-5, corresponding to AB828004
and AB828005, respectively) (Shojima et al., 2013b), and 10 non-
synonymous mutations in KoRV-J OJ-4 clone 11-4 (AB822553)
(Shojima et al., 2013b). None of the non-synonymous mutations
present in the GenBank entries was detected in the sequences
generated for this study. Importantly, all of the KoRV variants in
GenBank, including the KoRV-B and KoRV-J sequences, coded for
amino acid residues identical to those of p15-E1 in epitope 1, epitope
2, and the immunosupprressive domain.
Protein structure modeling
We examined the effects of non-synonymous variation on the
protein structure of p15E in recently published variants of KoRV
reported to be exogenous (Shojima et al., 2013b; Xu et al., 2013). We
did not ﬁnd any major changes in these variants (Figs. 3 and 4, Table
S3). We also examined the potential effects of non-synonymous
variation among newly generated sequences on the protein structure
of KoRV p15E, using the most common p15E-1 polypeptide as a
reference for three-dimensional modeling of the protein and all
structural comparisons (Fig. S1). Both E1 and E2 were highly
conserved among the different KoRV amino acid variants except
L33P (E1, p15E-23) and E130G (E2, p15E-16), each of which appeared
in the currently generated sequences only once (Fig. 2, Table 1). The
immunosuppressive domain, which is highly conserved across retro-
viruses, was also conserved among the KoRV p15E amino acid
variants, with only two variants, each detected only once among
the 163 sequences (in p15E-7 and p15E-10). The structural models
revealed that although overall the structure was highly conserved
there were several changes affecting atom conformations and local
surface charge (Figs. S1). Speciﬁcally, four amino acid variants (A8T,
S54F, C94Y, and A145T) exchanged a buried or partially buried amino
acid for a surface residue. Six variants (E93G, E130G, L159P, V163A,
R184G, and E193A), ﬁve of which were “radical” (deﬁned as non-
synonymous mutations with a negative score in both BLOSUM62 and
BLOSUM90 substitution matrices), had the opposite effect. Thirteen
amino acid variants, ﬁve of which were radical substitutions (S23P,
L33P, L76P, F96S, and S101P), would not affect the localization of the
R-group (Figs. 1, 2, and S1 and Table S2). Furthermore, several amino
acid variations resulted in extensive local changes in the surface
electrostatic potential of the protein structure (Table S2). Speciﬁcally,
mutations A8T, A145T, K82E, N172D, and K82E would increase the
local negative surface charge, while E93G, S101P, E193E, and N165D
would increase the local positive charge (Fig. S1, Table S2). Addition-
ally, six amino acid variants, S54F, L76P, K82E, E93G, C94Y, and F96S,
ﬁve of which were radical (Fig. S1, Table S2), were found to change
functional (as inferred by CDD) amino acids relative to p15E-1 (Fig.
S2). These were located within ectodomain HR1 and HR2, two of
them were at the immunosuppressive domain (L76P, K82E), and one
(S54F) was part of the homotrimer interface.
Fig. 3. Structural superimpositions between KoRV p15E-1 and KoRV variants reported as exogenous. The KoRV p15E-1 protein structure, which was used as a reference
structure is shown in white and three other KoRVs reported to be exogenous (Shojima et al., 2013b; Xu et al., 2013) are shown in black. Shown are (top panels) a comparison
between KoRV p15E-1 and KoRV-B; (middle panels) a comparison between KoRV p15E-1 and KoRV-J (OJ-4 clone 11-4); and (bottom panels) a comparison between KoRV
p15E-1 and KoRV-J OJ-4 11-1 (OJ-4 clone 11-1; identical to clones 11-2 and 11-5). All comparisons demonstrate the overall similarity of the structures. Amino acid variations
between sequences mapped on the protein models are shown. These are colored cyan for p15E-1 and red for all the other KoRVs. These variable amino acid residues are
depicted in line representations to visualize the atoms. The models are presented in cartoon ribbon representations.
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Signatures of selection
To examine whether p15E has been under selection, the 163
sequences with intact ORFs generated in this report were used to
estimate Tajima's D, which is a test of neutrality (Tajima, 1989). If
the value of Tajima's D is not signiﬁcantly different from zero
this provides support for neutrality. Tajima's D was 2.28 with 12
segregating sites and π (nucleotide diversity) of 0.0009. This strongly
negative value for Tajima's D suggested that p15E has been under
purifying selection. Strong evidence for purifying selection was also
provided by other analyses of the coding region: a low dN/dS ratio
(0.3) with dN¼0.00370.001 (the number of nonsynonymous sub-
stitutions per nonsynonymous site) and dS¼0.01070.002 (the
number of synonymous substitutions per synonymous site); and
the results of a codon-based Z-test of purifying selection, which
averaged over all sequence pairs showed signiﬁcant deviation from
neutrality (p¼0.002, Z¼2.92, one-tailed test).
Discussion
The KoRV p15E protein contains an immunosuppressive
domain that is highly conserved among different retroviruses
(Denner et al., 1994). In HIV-1, single mutations in this domain
have been shown to reduce IL-10 release, which implies that
the immunosuppressive activity by HIV is abrogated by these
mutations, although the impacts are different depending on the
position of the mutation. Additionally, rats immunized with a
mutated immunosuppressive domain of HIV-1 show higher anti-
body response (Morozov et al., 2012). Among HIV-1 infected
patients, mutations that abrogate immunosuppressive activity
are not common and it appears that viruses with a mutated
immunosuppressive domain are selectively eliminated by the
immune system, since the immunosuppressive domain suppresses
antibody response in vivo (Morozov et al., 2012). Culturing KoRV
with human peripheral blood mononuclear cells results in higher
IL-10 production, which suggests that KoRV is immunosuppressive
(Fiebig et al., 2006). The high conservation of the immunosup-
pressive domain across KoRV, GALV, and PERV (Fig. 1) suggests
that p15E plays an important functional role in KoRV, as does our
ﬁnding that p15E showed signatures of purifying selection.
Furthermore, the p15E region contains the HR1 and HR2 motifs,
the homotrimer interface; a chloride ion binding site; and the CX
(6)C motif. We found that these domains are highly conserved
across proviruses including KoRV variants reported to be exogen-
ous: KoRV-B (Xu et al., 2013) and KoRV-J (Shojima et al., 2013b).
Only a few mutations were predicted to affect protein structure,
function, or antigenicity. A detailed study of PERV has shown that
antibodies are directed only against epitope 2 (MPER) of p15E and
not against epitope 1 (FPPR) (Waechter and Denner, 2014). We
found one haplotype with an amino acid change in each of epitope
1 (p15E-23) and epitope 2 (p15E-16). Importantly, the variants in
Fig. 4. The distribution of the electrostatic potential on the solvent-accessible surfaces of p15E is highly conserved. The electrostatic potential of KoRV p15E-1 (left panels) is
compared to those of (right panels, top to bottom): KoRV-B, KoRV-J (OJ-4 clone 11-4) and KoRV-J OJ-4 11-1 (OJ-4 clone 11-1; identical to clones 11-2 and 11-5) (Shojima et al.,
2013b; Xu et al., 2013). A notable difference due to mutations found in KoRV-J (OJ-4 11-4) sequence is shownwith a yellow arrow (right middle panel). The regions colored in
blue represent positively-charged groups, red represents negative charges, and white-gray areas are electrically neutral. Structures of all proteins are shown in equivalent
orientations and are seen from two alternate views differing by 1801. The models are shown as semi-transparent surfaces to visualize the secondary elements and amino acid
chains.
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these epitopes were not predicted to greatly inﬂuence the protein
structure. These epitopes were also highly conserved in KoRVs
reported to be exogenous: KoRV-B (Xu et al., 2013) and KoRV-J
(Shojima et al., 2013b). This suggests the possibility that all KoRVs
might be neutralized by vaccines developed using KoRV p15E.
The signature of purifying selection suggests that mutations in
p15E had been deleterious for KoRV, and would explain why p15E
remains conserved among different proviruses. The sequences on
which these tests of selection were based may be derived from
either exogenous or endogenous KoRVs. However, in a recent
study of LTRs in endogenous KoRVs, it was determined that all of
the detectable mutations present across endogenous KoRVs had
occurred while the virus was still exogenous, and that not enough
time had elapsed since endogenization for any mutations to have
occurred across the ca. 10,000 bp of enKoRV sequences examined
(Ishida et al., 2014). Thus the variation detected among KoRVs in
our dataset is likely to reﬂect mutations and selection pressure
that occurred only among exogenous KoRVs, even if these were
detected among proviruses that had subsequently endogenized.
Despite a high degree of conservation and purifying selection,
we found some mutations that may alter the structure and function
of speciﬁc p15E domains, which are also likely to represent changes
present before KoRV endogenized (Ishida et al., 2014). Protein
modeling suggested that two radical substitutions in the immuno-
suppressive domain may affect the local protein conformation and
alter the surface charge. These drastic changes could potentially
alter the function of the highly conserved immunosuppressive
domain. Because these variants were also detected in museum
specimens, they are unlikely to represent cloning errors although
each of the variants was detected by our study in only a single
clonal sequence. There were four other variants in the trimer
interface and the two viral ectodomains that affected amino acids
of known function. These variants were predicted to alter the
protein structure locally and may affect the trimerization, fusion,
and infection of the viruses. Additionally, in some other cases the
location of the R-group was altered and surface amino acids were
exchanged for buried residues and vice versa. These changes could
have important functional implications, because they may generate
new or alleviate pre-existing antigenic sites, which may result in
differences in immune response. Moreover, we found that certain
amino acid variations (Fig. S2) were predicted to drastically change
the local surface charge. Such changes in the KoRV p15E domain
could have important biological implications, as has been shown for
other viruses, where changes in charge surrounded pockets and
electrostatic interactions with small molecules were found to affect
trimer assembly, membrane fusion, and viral entry (Ramsdale et al.,
1996; Zhu et al., 1998). Some of the variants were also identiﬁed in
museum specimens (Fig. 2) suggesting that the variants persisted
over time. Some variants, especially the ones that were not in
frame, may represent proviruses that are not replication competent.
Additionally some of the non-synonymous mutations may have
occurred in endogenous KoRVs, after the proviruses integrated into
the host germ line, in which case sequences with unusual muta-
tions may not be expressed, and thus would have little or no
relevance to the utility of a vaccine geared towards koalas unaf-
fected by KoRV.
The transmembrane envelope protein p15E has been used in
immunizing animals against gammaretroviruses (Denner et al.,
2012; Kaulitz et al., 2011; Langhammer et al., 2011; Waechter et al.,
2013). With the exception of FeLV in cats, studies of p15E as a
vaccine candidate have not been conducted using the viral host
species. Vaccines for FeLV currently rely on inactivated whole virus
or on the non-glycosylated surface envelope protein, although
neither type provides full protection, and p15E has been proposed
as being of potential beneﬁt for vaccination (Fiebig et al., 2003;
Langhammer et al., 2006).
The current study found that p15E was highly conserved
among KoRV proviruses in koalas from northern and southern
Australia and in KoRV variants reported to be exogenous; that
functional domains including the immunosuppressive domain and
several epitopes were highly conserved between KoRV and similar
retroviruses; and that none of the non-synonymous variation
detected within KoRV in the two epitopes would greatly affect
protein structure. KoRV p15E has been shown to induce neutraliz-
ing antibodies (Fiebig et al., 2006), suggesting that KoRV p15E may
be a potential candidate for vaccine development. Of course,
before widespread use, vaccine trials would be necessary to
demonstrate their efﬁcacy in providing protective immunity
against KoRV in koalas. Vaccines would also have to be tested for
safety, to ensure that they do not trigger unexpected side effects.
These may be of particular concern in the case of KoRV since many
koalas carry endogenous copies of KoRV that are present in every
nucleated cell. In any future studies, it would be important to
consider that the effects of any potential vaccine may vary
depending on whether or not an individual koala carries endo-
genous copies of KoRV.
Materials and methods
Sample collection and DNA extraction
Ethical approval for this study was provided by the University
of Illinois Institutional Animal Care and Use Committee, approved
protocol number 12040. The koalas were chosen based on their
known KoRV-positive status and their geographic diversity. They
included three wild southern Australian koalas, one each from the
Stony Rises (Pci-157) and the Brisbane Ranges (Pci-128) of Victoria,
and one from Kangaroo Island (Pci-182) of South Australia. The
southern koala samples had been collected in 1988 by the
Laboratory of Genomic Diversity, National Cancer Institute, USA,
under permit no. 87-150 issued by the Department of Conserva-
tion, Forests and Land, Victoria (Taylor et al., 1991). Their DNA had
been extracted using a phenol-chloroform method at NCI, and sent
to UIUC under Materials Transfer Agreement 2008-05798-01-00.
One northern Australian (Queensland) zoo koala was also inclu-
ded, “Bunyip”, Pci-SN404 (“SN” represents the North American
Regional Studbook number). The American Zoo Association's
Species Survival Plan (AZA SSP) manages northern (Queensland)
and southern koalas separately and the pedigrees are well char-
acterized. The inbreeding coefﬁcient of Pci-SN404 was estimated
to be very low (fﬃ0.008). After the approval of the AZA koala SSP
Management Group, the blood sample for Pci-SN404 was collected
during a regular physical examination on September 2, 2010, at
4 years of age, with DNA extracted using the QIAamp DNA Blood
Mini Kit from Qiagen (Valencia, CA).
PCR, cloning, and sequencing
The position of p15E in KoRV (GenBank: AF151794) (Hanger
et al., 2000) was determined based on homology to gibbon ape
leukemia virus (GALV; GenBank: NC_001885) (Delassus et al.,
1989) and feline leukemia virus (FeLV; GenBank: NC_001940)
(Chen et al., 1998). Primers for PCR were designed using the
software Primer3 (http://fokker.wi.mit.edu/primer3/input.htm)
(Rozen and Skaletsky, 2000) to target conserved DNA regions, as
determined by an alignment of KoRV sequences DQ174772 (Fiebig
et al., 2006) and AF151794 (Hanger et al., 2000), and to amplify
the complete p15E region in a single ampliﬁcation. Two alterna-
tive primer pairs were designed: p15E-F1 (CAGACGGTACCTTGC-
TACAGG) with p15E-R1 (CCTTCATTCCCCCATTTTCT) for an ampli-
con size of 693 bp; and p15E-F2 (GCTTGTCCCTCGCATCTACT) with
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p15E-R2 (TTTTCTTTGAGGGTAGCTCTAATCA) for an amplicon size
of 705 bp. For every koala, separate PCRs were run using each of
the primer pairs.
PCR mixes included ﬁnal concentrations of 0.4 mM of each
primer, 1.5 mM MgCl2, 200 mM of each dNTP (Life Technologies
Corp., Carlsbad, CA), 0.8 mg/ml of bovine serum albumin (BSA; New
England BioLabs Inc., Ipswich, MA) and 0.04 units/ml of AmpliTaq
DNA Polymerase (Life Technologies Corp.). The PCR algorithm
consisted of an initial denaturation at 95 1C for 5 min; followed by
cycles of denaturation for 20 s at 94 1C, annealing for 3 cycles of 30 s
at 60 1C, decreasing in subsequent cycles to 58 1C, 56 1C, 54 1C, 52 1C
(5 cycles each) or 50 1C (ﬁnal 22 cycles), and a 1 min extension at
72 1C; with a ﬁnal extension of 7 min at 72 1C. An aliquot of each PCR
product was examined on a 1% ethidium bromide stained agarose
gel under ultraviolet light. PCR amplicons were treated with
Exonuclease I (USB Corporation, Cleveland, OH) and shrimp alkaline
phosphate (USB Corporation) to remove excess primers and unin-
corporated dNTPs (Hanke and Wink, 1994). Sanger sequencing was
conducted as previously described (Ishida et al., 2011) and used the
ABI 3730XL capillary sequencer at the UIUC Core DNA Sequencing
Facility. Sequencher 5.1 (Gene Codes Corp.) was used to examine,
edit and concatenate the sequences.
After Sanger sequencing veriﬁed that primers had ampliﬁed the
target region, PCR products were cloned using a TOPO TA Cloning kit
(Life Technologies Corp.) following the manufacturer's instructions.
We examined the number of clones that would with 95% conﬁdence
identify minor alleles and haplotypes present at a frequency of 2.5%
or more, and that would also identify a large majority of those
present at 1% frequency. Forty-eight colonies from each koala
sample were directly PCR-ampliﬁed following the protocol above
(but without the use of BSA). Amplicons were examined on a gel,
puriﬁed, and Sanger-sequenced following the procedures described
above. The sequences were edited, trimmed to include only the p15E
coding region and aligned using the software Sequencher 5.1 (Gene
Codes Corp.). All distinct sequences that coded p15E-1 to p15E-24
were deposited in GenBank, under accession numbers KJ764672–
KJ764710. Non-synonymous polymorphisms that appeared only
once among the clones were suspected of being cloning artifacts;
to minimize this possibility, these polymorphisms were searched for
among the polymorphisms that had been previously detected
among samples of 7 museum koalas (Tsangaras et al., 2014).
Identiﬁcation of protein domains and functional residues, and protein
modeling
MEGA 5.2 (Tamura et al., 2011) was used to translate and align the
amino acid sequences. The positions of KoRV epitope 1 (E1), epitope 2
(E2), and the immunosuppressive domain were inferred based on
homology to the corresponding regions in pig endogenous retrovirus
(PERV) (Fiebig et al., 2003) and other retroviruses (Denner et al., 1994).
Transmembrane helices were identiﬁed using the software HMMTOP
(http://www.enzim.hu/hmmtop) (Tusnady and Simon, 1998, 2001).
Domains in the amino acid sequences were identiﬁed using the
Conserved Domains Database (CDD) of NCBI (http://www.ncbi.nlm.
nih.gov/Structure/cdd/cdd.shtml) (Marchler-Bauer et al., 2013). The
Conserved Features/Sites option of the CDD was used to examine
whether non-synonymous mutations were present within protein
regions of known function. Those non-synonymous mutations that
produced a negative score in both BLOSUM62 and BLOSUM90 sub-
stitution matrices were deﬁned as “radical.”
To determine the structural characteristics of KoRV protein
variants, their three-dimensional (3D) structures were predicted.
The p15E-1 sequence was used as a reference and its 3D structure
was predicted using the I-TASSER server (http://zhanglab.ccmb.med.
umich.edu/I-TASSER/) (Roy et al., 2010; Roy et al., 2012; Zhang, 2008).
I-TASSER uses a combination of alignments, threading, simulations,
and structural assemblies to generate a ﬁnal model (Roy et al., 2010;
Roy et al., 2012; Zhang, 2008). Because the structure of KoRV has not
been solved experimentally, to model KoRV p15E, a combination of
different structural data was used from several retroviral proteins:
2xz3A, bovine leukemia virus; 1eboA, Ebola virus; 4g2kA, Marburg
virus; 1y4mA, human syncytin-2 (endogenous retrovirus); 1mofA,
Moloney murine leukemia virus (MoMuLV); and 3s88J, Sudan Ebola
virus. These structures were utilized to generate the model because
they had the highest percentage of identity to KoRV p15E sequence
and they produced high conﬁdence threading alignments (Roy et al.,
2010; Roy et al., 2012; Zhang, 2008). Then each of the variant
proteins was modeled using the p15E-1 structure as a reference
using the SWISS-MODEL server (http://swissmodel.expasy.org/)
(Arnold et al., 2006). Using this strategy the whole p15E region could
be reliably modeled. Pairwise structural alignments and structural
superimpositions were performed using the DaliLite server (http://
www.ebi.ac.uk/Tools/structure/dalilite/) (Holm and Park, 2000).
Models and ﬁgures were drawn using Pymol (DeLano Scientiﬁc).
Tests of selection
MEGA, version 5.2 (Tamura et al., 2011) was used to implement
the Nei-Gojobori method of determining the proportion of synon-
ymous substitutions per synonymous sites and the proportion of
non-synonymous substitutions per non-synonymous sites; to
estimate Tajima's D (D¼0: neutral, Do0: purifying selection,
D40: balancing selection); and to implement the codon-based
Z-test of purifying selection using bootstrapping (1000 replicates).
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